Assessment of the patient's inflammatory phenotype is recommended if severe asthma persists despite optimized therapy. According to the GINA report, determining if the patient has type 2 or non-type 2 severe asthma can help optimize treatment choice with a targeted therapy.
Learn more about severe asthma phenotypes.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Zab Mosenifar. Fast Five Quiz: Severe Asthma - Medscape - Mar 17, 2023.